Choose from 5 options:
2. Types of assessment applications and information required
On this page
Introduction
This page explains the types of assessments certificates you can apply for, and the information you must have to support the assessment certificate type you choose.
There are 4 types of assessment certificates based on your categorisation outcome which you must have established by using our Guide to categorising your chemical importation and manufacture.
- Health and environment focus
- Health focus
- Environment focus
- Very low to low risk
Health and environment focus applications and information required
Choose this application if:
- your introduction’s indicative human health risk is medium to high, and the indicative environment risk is medium to high, or
- you do not have necessary data to demonstrate that the highest indicative risk of the introduction to both human health and the environment is low or very low.
Note: The numbers in brackets represent the document numbers in IUCLID6 Version 4.18.0.
| IUCLID documentation | Medium to high risk for health and environment | |
|---|---|---|
| Sections | Subsections / Documents | Required / If available |
| 1. General information | Identification (1.1) | Required |
| Composition (1.2) | Required | |
| Analytical information (1.4) | Required | |
| 2. Classification, labelling | GHS (2.1) | Required |
| 3. Manufacture | Estimated quantities (3.2) | Required |
| Site (3.3) | Required for manufacture only | |
| Manufacture (3.5.1) | Required for manufacture only | |
| Formulation or re-packing (3.5.2) | If available – though at least one use must be provided in either 3.5.2, 3.5.3, 3.5.4 or 3.5.5. | |
| Uses at industrial sites (3.5.3) | ||
| Widespread uses by professional workers (3.5.4) | ||
| Consumer uses (3.5.5) | ||
| Article service life (3.5.6) | If available | |
| 4. Physical and chemical properties | Appearance / physical state / colour (4.1) | Required |
| Melting point / freezing point (4.2) | Required | |
| Boiling point (4.3) | Required | |
| Density (4.4) | Required | |
| Particle size distribution (Granulometry) (4.5) | Required | |
| Vapour pressure (4.6) | Required | |
| Partition coefficient (4.7) | Required | |
| Water solubility (4.8) | Required | |
| Solubility in organic solvents / fat solubility (4.9) | If available | |
| Surface tension (4.10) | If available | |
| Flash point (4.11) | Required | |
| Auto flammability (4.12) | Required | |
| Flammability (4.13) | Required | |
| Explosiveness (4.14) | Required | |
| Oxidising properties (4.15) | Required | |
| Oxidation reduction potential (4.16) | If available | |
| pH (4.20) | If available | |
| Dissociation constant (4.21) | Required | |
| Viscosity (4.22) | If available | |
| Self-reactive substances (4.23) | If available | |
| Additional physico-chemical information (4.27) | If available | |
| Nanomaterial agglomeration / aggregation (4.28.1) | If available | |
| Nanomaterial crystalline phase (4.28.2) | If available | |
| Nanomaterial crystallite and grain size (4.28.3) | If available | |
| Nanomaterial aspect ratio / shape (4.28.4) | If available | |
| Nanomaterial specific surface area (4.28.5) | If available | |
| Nanomaterial Zeta potential (4.28.6) | If available | |
| Nanomaterial surface chemistry (4.28.7) | If available | |
| Nanomaterial dustiness (4.28.8) | If available | |
| Nanomaterial porosity (4.28.9) | If available | |
| Nanomaterial pour density (4.28.10) | If available | |
| Nanomaterial photocatalytic activity (4.28.11) | If available | |
| Nanomaterial radical formation potential (4.28.12) | If available | |
| Nanomaterial catalytic activity (4.28.13) | If available | |
| Nanomaterial dispersion stability (4.28.14) | If available | |
| 5. Environmental fate and pathways | Phototransformation in air (5.1.1) | If available |
| Hydrolysis (5.1.2) | Required | |
| Phototransformation in water (5.1.3) | If available | |
| Biodegradation in water: screening tests (5.2.1) | Required | |
| Biodegradation in soil (5.2.3) | If available | |
| Bioaccumulation: aquatic / sediment (5.3.1) | Required (information on either 5.3.1 or 5.3.2) | |
| Bioaccumulation: terrestrial (5.3.2) | ||
| Adsorption / desorption (5.4.1) | Required | |
| Henry’s Law constant (5.4.2) | If available | |
| Other distribution data (5.4.4) | If available | |
| Additional information on environmental fate and behaviour (5.6) | If available | |
| 6. Ecotoxicological information | Short-term toxicity to fish (6.1.1) | Required |
| Long-term toxicity to fish (6.1.2) | If available | |
| Short-term toxicity to aquatic invertebrates (6.1.3) | Required | |
| Long-term toxicity to aquatic invertebrates (6.1.4) | If available | |
| Toxicity to aquatic algae and cyanobacteria (6.1.5) | Required | |
| Toxicity to aquatic plants other than algae (6.1.6) | If available | |
| Toxicity to microorganisms (6.1.7) | If available | |
| Endocrine disruptor testing in aquatic vertebrates – in vivo (6.1.8) | If available | |
| Toxicity to other aquatic vertebrates (6.1.9) | If available | |
| Sediment toxicity (6.2) | If available | |
| Toxicity to soil macroorganisms except arthropods (6.3.1) | If available | |
| Toxicity to terrestrial arthropods (6.3.2) | If available | |
| Toxicity to terrestrial plants (6.3.3) | If available | |
| Toxicity to soil microorganisms (6.3.4) | If available | |
| Additional ecotoxicological information (6.6) | If available | |
| 7. Toxicological information | Basic toxicokinetics (7.1.1) | If available |
| Dermal absorption (7.1.2) | If available | |
| Acute toxicity: oral (7.2.1) | Required (information on either 7.2.1, 7.2.2 or 7.2.3.) | |
| Acute toxicity: inhalation (7.2.2) | ||
| Acute toxicity: dermal (7.2.3) | ||
| Acute toxicity: other routes (7.2.4) | If available | |
| Skin irritation / corrosion (7.3.1) | Required | |
| Eye irritation (7.3.2) | Required | |
| Skin sensitisation (7.4.1) | Required | |
| Respiratory sensitisation (7.4.2) | If available | |
| Repeated dose toxicity: oral (7.5.1) | Required (information on either 7.5.1, 7.5.2 or 7.5.3) | |
| Repeated dose toxicity: inhalation (7.5.2) | ||
| Repeated dose toxicity: dermal (7.5.3) | ||
| Repeated dose toxicity: other routes (7.5.4) | If available | |
| Genetic toxicity in vitro (7.6.1) | Required. Information on point mutations (7.6.1 or 7.6.2) and chromosome damage (7.6.1 or 7.6.2) | |
| Genetic toxicity in vivo (7.6.2) | ||
| Carcinogenicity (7.7) | If available | |
| Toxicity to reproduction (7.8.1) | If available | |
| Developmental toxicity / teratogenicity (7.8.2) | If available | |
| Toxicity to reproduction: other studies (7.8.3) | If available | |
| Neurotoxicity (7.9.1) | If available | |
| Immunotoxicity (7.9.2) | If available | |
| Specific investigations: other studies (7.9.4) | If available | |
| Health surveillance data (7.10.1) | If available | |
| Epidemiological data (7.10.2) | If available | |
| Direct observations: clinical cases, poisoning incidents and other (7.10.3) | If available | |
| Sensitisation data (humans) (7.10.4) | If available | |
| Exposure related observations in humans: other data (7.10.5) | If available | |
| Additional toxicological information (7.12) | If available | |
| 9. Residues in food and feeding stuff | If available | |
| 11. Guidance on safe use | Required | |
| 13. Assessment report (attach SDS) | Required | |
Health focus applications and information required
Choose this application if your introduction’s indicative human health risk is medium to high, and the indicative environment risk is very low to low.
You will need to be able to demonstrate that the highest indicative risk of the introduction to the environment is very low or low risk. If you can’t do this, choose ‘Health and environment focus’.
Note: The numbers in brackets represent the document numbers in IUCLID6 Version 4.18.0.
| IUCLID documentation | Medium to high risk for health and low to very low risk for environment | |
|---|---|---|
| Sections | Subsections / Documents | Required / If available |
| 1. General information | Identification (1.1) | Required |
| Composition (1.2) | Required | |
| Analytical information (1.4) | Required | |
| 2. Classification, labelling | GHS (2.1) | Required |
| 3. Manufacture | Estimated quantities (3.2) | Required |
| Site (3.3) | Required for manufacture only | |
| Manufacture (3.5.1) | Required for manufacture only | |
| Formulation or re-packing (3.5.2) | If available – though at least one use (use name) must be provided in either 3.5.2, 3.5.3, 3.5.4 or 3.5.5. | |
| Uses at industrial sites (3.5.3) | ||
| Widespread uses by professional workers (3.5.4) | ||
| Consumer uses (3.5.5) | ||
| Article service life (3.5.6) | If available | |
| 4. Physical and chemical properties | Appearance / physical state / colour (4.1) | Required |
| Melting point / freezing point (4.2) | Required | |
| Boiling point (4.3) | Required | |
| Density (4.4) | Required | |
| Particle size distribution (Granulometry) (4.5) | Required | |
| Vapour pressure (4.6) | Required | |
| Partition coefficient (4.7) | Required | |
| Water solubility (4.8) | Required | |
| Solubility in organic solvents / fat solubility (4.9) | If available | |
| Surface tension (4.10) | If available | |
| Flash point (4.11) | Required | |
| Auto flammability (4.12) | Required | |
| Flammability (4.13) | Required | |
| Explosiveness (4.14) | Required | |
| Oxidising properties (4.15) | Required | |
| Oxidation reduction potential (4.16) | If available | |
| pH (4.20) | If available | |
| Dissociation constant (4.21) | Required | |
| Viscosity (4.22) | If available | |
| Self-reactive substances (4.23) | If available | |
| Additional physico-chemical information (4.27) | If available | |
| Nanomaterial agglomeration / aggregation (4.28.1) | If available | |
| Nanomaterial crystalline phase (4.28.2) | If available | |
| Nanomaterial crystallite and grain size (4.28.3) | If available | |
| Nanomaterial aspect ratio / shape (4.28.4) | If available | |
| Nanomaterial specific surface area (4.28.5) | If available | |
| Nanomaterial Zeta potential (4.28.6) | If available | |
| Nanomaterial surface chemistry (4.28.7) | If available | |
| Nanomaterial dustiness (4.28.8) | If available | |
| Nanomaterial porosity (4.28.9) | If available | |
| Nanomaterial pour density (4.28.10) | If available | |
| Nanomaterial photocatalytic activity (4.28.11) | If available | |
| Nanomaterial radical formation potential (4.28.12) | If available | |
| Nanomaterial catalytic activity (4.28.13) | If available | |
| Nanomaterial dispersion stability (4.28.14) | If available | |
| 5. Environmental fate and pathways | Phototransformation in air (5.1.1) | If available |
| Hydrolysis (5.1.2) | Required | |
| Phototransformation in water (5.1.3) | If available | |
| Biodegradation in water: screening tests (5.2.1) | If available | |
| Biodegradation in soil (5.2.3) | If available | |
| Bioaccumulation: aquatic / sediment (5.3.1) | If available | |
| Bioaccumulation: terrestrial (5.3.2) | If available | |
| Adsorption / desorption (5.4.1) | Required | |
| Henry’s Law constant (5.4.2) | If available | |
| Other distribution data (5.4.4) | If available | |
| Additional information on environmental fate and behaviour (5.6) | If available | |
| 6. Ecotoxicological information | Short-term toxicity to fish (6.1.1) | If available |
| Long-term toxicity to fish (6.1.2) | If available | |
| Short-term toxicity to aquatic invertebrates (6.1.3) | If available | |
| Long-term toxicity to aquatic invertebrates (6.1.4) | If available | |
| Toxicity to aquatic algae and cyanobacteria (6.1.5) | If available | |
| Toxicity to aquatic plants other than algae (6.1.6) | If available | |
| Toxicity to microorganisms (6.1.7) | If available | |
| Endocrine disruptor testing in aquatic vertebrates – in vivo (6.1.8) | If available | |
| Toxicity to other aquatic vertebrates (6.1.9) | If available | |
| Sediment toxicity (6.2) | If available | |
| Toxicity to soil macroorganisms except arthropods (6.3.1) | If available | |
| Toxicity to terrestrial arthropods (6.3.2) | If available | |
| Toxicity to terrestrial plants (6.3.3) | If available | |
| Toxicity to soil microorganisms (6.3.4) | If available | |
| Additional ecotoxicological information (6.6) | If available | |
| 7. Toxicological information | Basic toxicokinetics (7.1.1) | If available |
| Dermal absorption (7.1.2) | If available | |
| Acute toxicity: oral (7.2.1) | Required (information on either 7.2.1, 7.2.2 or 7.2.3) | |
| Acute toxicity: inhalation (7.2.2) | ||
| Acute toxicity: dermal (7.2.3) | ||
| Acute toxicity: other routes (7.2.4) | If available | |
| Skin irritation / corrosion (7.3.1) | Required | |
| Eye irritation (7.3.2) | Required | |
| Skin sensitisation (7.4.1) | Required | |
| Respiratory sensitisation (7.4.2) | If available | |
| Repeated dose toxicity: oral (7.5.1) | Required (information on either 7.5.1, 7.5.2 or 7.5.3) | |
| Repeated dose toxicity: inhalation (7.5.2) | ||
| Repeated dose toxicity: dermal (7.5.3) | ||
| Repeated dose toxicity: other routes (7.5.4) | If available | |
| Genetic toxicity in vitro (7.6.1) | Required. Information on point mutations (7.6.1 or 7.6.2) and chromosome damage (7.6.1 or 7.6.2) | |
| Genetic toxicity in vivo (7.6.2) | ||
| Carcinogenicity (7.7) | If available | |
| Toxicity to reproduction (7.8.1) | If available | |
| Developmental toxicity / teratogenicity (7.8.2) | If available | |
| Toxicity to reproduction: other studies (7.8.3) | If available | |
| Neurotoxicity (7.9.1) | If available | |
| Immunotoxicity (7.9.2) | If available | |
| Specific investigations: other studies (7.9.4) | If available | |
| Health surveillance data (7.10.1) | If available | |
| Epidemiological data (7.10.2) | If available | |
| Direct observations: clinical cases, poisoning incidents and other (7.10.3) | If available | |
| Sensitisation data (humans) (7.10.4) | If available | |
| Exposure related observations in humans: other data (7.10.5) | If available | |
| Additional toxicological information (7.12) | If available | |
| 9. Residues in food and feeding stuff | If available | |
| 11. Guidance on safe use | Required | |
| 13. Assessment report (attach SDS) | Required | |
Environment focus applications and information required
Choose this application if your introduction’s indicative human health risk is very low to low, and the indicative environment risk is medium to high
You will need to be able to demonstrate that the highest indicative human health risk of the introduction is very low or low risk. If you can’t do this, choose ‘Health and environment focus’.
Environment focus – information required
Note: The numbers in brackets represent the document numbers in IUCLID6 Version 4.18.0.
| IUCLID documentation | Medium to high risk for environment and low to very low risk for health | |
|---|---|---|
| Sections | Subsections / Documents | Required / If available |
| 1. General information | Identification (1.1) | Required |
| Composition (1.2) | Required | |
| Analytical information (1.4) | Required | |
| 2. Classification, labelling | GHS (2.1) | Required |
| 3. Manufacture | Estimated quantities (3.2) | Required |
| Site (3.3) | Required for manufacture only | |
| Manufacture (3.5.1) | Required for manufacture only | |
| Formulation or re-packing (3.5.2) | If available – though at least one use (use name) must be provided in either 3.5.2, 3.5.3, 3.5.4 or 3.5.5. | |
| Uses at industrial sites (3.5.3) | ||
| Widespread uses by professional workers (3.5.4) | ||
| Consumer uses (3.5.5) | ||
| Article service life (3.5.6) | If available | |
| 4. Physical and chemical properties | Appearance / physical state / colour (4.1) | Required |
| Melting point / freezing point (4.2) | Required | |
| Boiling point (4.3) | Required | |
| Density (4.4) | Required | |
| Particle size distribution (Granulometry) (4.5) | Required | |
| Vapour pressure (4.6) | Required | |
| Partition coefficient (4.7) | Required | |
| Water solubility (4.8) | Required | |
| Solubility in organic solvents / fat solubility (4.9) | If available | |
| Surface tension (4.10) | If available | |
| Flash point (4.11) | If available | |
| Auto flammability (4.12) | If available | |
| Flammability (4.13) | If available | |
| Explosiveness (4.14) | If available | |
| Oxidising properties (4.15) | If available | |
| Oxidation reduction potential (4.16) | If available | |
| pH (4.20) | If available | |
| Dissociation constant (4.21) | Required | |
| Viscosity (4.22) | If available | |
| Self-reactive substances (4.23) | If available | |
| Additional physico-chemical information (4.27) | If available | |
| Nanomaterial agglomeration / aggregation (4.28.1) | If available | |
| Nanomaterial crystalline phase (4.28.2) | If available | |
| Nanomaterial crystallite and grain size (4.28.3) | If available | |
| Nanomaterial aspect ratio / shape (4.28.4) | If available | |
| Nanomaterial specific surface area (4.28.5) | If available | |
| Nanomaterial Zeta potential (4.28.6) | If available | |
| Nanomaterial surface chemistry (4.28.7) | If available | |
| Nanomaterial dustiness (4.28.8) | If available | |
| Nanomaterial porosity (4.28.9) | If available | |
| Nanomaterial pour density (4.28.10) | If available | |
| Nanomaterial photocatalytic activity (4.28.11) | If available | |
| Nanomaterial radical formation potential (4.28.12) | If available | |
| Nanomaterial catalytic activity (4.28.13) | If available | |
| Nanomaterial dispersion stability (4.28.14) | If available | |
| 5. Environmental fate and pathways | Phototransformation in air (5.1.1) | If available |
| Hydrolysis (5.1.2) | Required | |
| Phototransformation in water (5.1.3) | If available | |
| Biodegradation in water: screening tests (5.2.1) | Required | |
| Biodegradation in soil (5.2.3) | If available | |
| Bioaccumulation: aquatic / sediment (5.3.1) | Required (information on either 5.3.1 or 5.3.2) | |
| Bioaccumulation: terrestrial (5.3.2) | ||
| Adsorption / desorption (5.4.1) | Required | |
| Henry’s Law constant (5.4.2) | If available | |
| Other distribution data (5.4.4) | If available | |
| Additional information on environmental fate and behaviour (5.6) | If available | |
| 6. Ecotoxicological information | Short-term toxicity to fish (6.1.1) | Required |
| Long-term toxicity to fish (6.1.2) | If available | |
| Short-term toxicity to aquatic invertebrates (6.1.3) | Required | |
| Long-term toxicity to aquatic invertebrates (6.1.4) | If available | |
| Toxicity to aquatic algae and cyanobacteria (6.1.5) | Required | |
| Toxicity to aquatic plants other than algae (6.1.6) | If available | |
| Toxicity to microorganisms (6.1.7) | If available | |
| Endocrine disruptor testing in aquatic vertebrates – in vivo (6.1.8) | If available | |
| Toxicity to other aquatic vertebrates (6.1.9) | If available | |
| Sediment toxicity (6.2) | If available | |
| Toxicity to soil macroorganisms except arthropods (6.3.1) | If available | |
| Toxicity to terrestrial arthropods (6.3.2) | If available | |
| Toxicity to terrestrial plants (6.3.3) | If available | |
| Toxicity to soil microorganisms (6.3.4) | If available | |
| Additional ecotoxicological information (6.6) | If available | |
| 7. Toxicological information | Basic toxicokinetics (7.1.1) | If available |
| Dermal absorption (7.1.2) | If available | |
| Acute toxicity: oral (7.2.1) | If available | |
| Acute toxicity: inhalation (7.2.2) | If available | |
| Acute toxicity: dermal (7.2.3) | If available | |
| Acute toxicity: other routes (7.2.4) | If available | |
| Skin irritation / corrosion (7.3.1) | If available | |
| Eye irritation (7.3.2) | If available | |
| Skin sensitisation (7.4.1) | If available | |
| Respiratory sensitisation (7.4.2) | If available | |
| Repeated dose toxicity: oral (7.5.1) | If available | |
| Repeated dose toxicity: inhalation (7.5.2) | If available | |
| Repeated dose toxicity: dermal (7.5.3) | If available | |
| Repeated dose toxicity: other routes (7.5.4) | If available | |
| Genetic toxicity in vitro (7.6.1) | If available | |
| Genetic toxicity in vivo (7.6.2) | If available | |
| Carcinogenicity (7.7) | If available | |
| Toxicity to reproduction (7.8.1) | If available | |
| Developmental toxicity / teratogenicity (7.8.2) | If available | |
| Toxicity to reproduction: other studies (7.8.3) | If available | |
| Neurotoxicity (7.9.1) | If available | |
| Immunotoxicity (7.9.2) | If available | |
| Specific investigations: other studies (7.9.4) | If available | |
| Health surveillance data (7.10.1) | If available | |
| Epidemiological data (7.10.2) | If available | |
| Direct observations: clinical cases, poisoning incidents and other (7.10.3) | If available | |
| Sensitisation data (humans) (7.10.4) | If available | |
| Exposure related observations in humans: other data (7.10.5) | If available | |
| Additional toxicological information (7.12) | If available | |
| 9. Residues in food and feeding stuff | If available | |
| 11. Guidance on safe use | Required | |
| 13. Assessment report (attach SDS) | Required | |
Very low to low risk applications and information required
You can select this if you have categorised your introduction as exempted or reported and you want your chemical to be added to the Inventory. If this is not the case, you do not need to apply for an assessment certificate for these categories.
Note: The numbers in brackets represent the document numbers in IUCLID6 Version 4.18.0.
| IUCLID documentation | Very low to low risk for health and environment risk | |
|---|---|---|
| Sections | Subsections / Documents | Required / If available |
| 1. General information | Identification (1.1) | Required |
| Composition (1.2) | Required | |
| Analytical information (1.4) | Required | |
| 2. Classification, labelling | GHS (2.1) | Required |
| 3. Manufacture | Estimated quantities (3.2) | Required |
| Site (3.3) | Required for manufacture only | |
| Manufacture (3.5.1) | Required for manufacture only | |
| Formulation or re-packing (3.5.2) | If available – though at least one use (use name) must be provided in either 3.5.2, 3.5.3, 3.5.4 or 3.5.5.
| |
| Uses at industrial sites (3.5.3) | ||
| Widespread uses by professional workers (3.5.4) | ||
| Consumer uses (3.5.5) | ||
| Article service life (3.5.6) | If available | |
| 4. Physical and chemical properties | Appearance / physical state / colour (4.1) | Required |
| Melting point / freezing point (4.2) | Required | |
| Boiling point (4.3) | Required | |
| Density (4.4) | Required | |
| Particle size distribution (Granulometry) (4.5) | Required | |
| Vapour pressure (4.6) | Required | |
| Partition coefficient (4.7) | Required | |
| Water solubility (4.8) | Required | |
| Solubility in organic solvents / fat solubility (4.9) | If available | |
| Surface tension (4.10) | If available | |
| Flash point (4.11) | If available | |
| Auto flammability (4.12) | If available | |
| Flammability (4.13) | If available | |
| Explosiveness (4.14) | If available | |
| Oxidising properties (4.15) | If available | |
| Oxidation reduction potential (4.16) | If available | |
| pH (4.20) | If available | |
| Dissociation constant (4.21) | Required | |
| Viscosity (4.22) | If available | |
| Self-reactive substances (4.23) | If available | |
| Additional physico-chemical information (4.27) | If available | |
| Nanomaterial agglomeration / aggregation (4.28.1) | If available | |
| Nanomaterial crystalline phase (4.28.2) | If available | |
| Nanomaterial crystallite and grain size (4.28.3) | If available | |
| Nanomaterial aspect ratio / shape (4.28.4) | If available | |
| Nanomaterial specific surface area (4.28.5) | If available | |
| Nanomaterial Zeta potential (4.28.6) | If available | |
| Nanomaterial surface chemistry (4.28.7) | If available | |
| Nanomaterial dustiness (4.28.8) | If available | |
| Nanomaterial porosity (4.28.9) | If available | |
| Nanomaterial pour density (4.28.10) | If available | |
| Nanomaterial photocatalytic activity (4.28.11) | If available | |
| Nanomaterial radical formation potential (4.28.12) | If available | |
| Nanomaterial catalytic activity (4.28.13) | If available | |
| Nanomaterial dispersion stability (4.28.14) | If available | |
| 5. Environmental fate and pathways | Phototransformation in air (5.1.1) | If available |
| Hydrolysis (5.1.2) | Required | |
| Phototransformation in water (5.1.3) | If available | |
| Biodegradation in water: screening tests (5.2.1) | If available | |
| Biodegradation in soil (5.2.3) | If available | |
| Bioaccumulation: aquatic / sediment (5.3.1) | If available | |
| Bioaccumulation: terrestrial (5.3.2) | If available | |
| Adsorption / desorption (5.4.1) | Required | |
| Henry’s Law constant (5.4.2) | If available | |
| Other distribution data (5.4.4) | If available | |
| Additional information on environmental fate and behaviour (5.6) | If available | |
| 6. Ecotoxicological information | Short-term toxicity to fish (6.1.1) | If available |
| Long-term toxicity to fish (6.1.2) | If available | |
| Short-term toxicity to aquatic invertebrates (6.1.3) | If available | |
| Long-term toxicity to aquatic invertebrates (6.1.4) | If available | |
| Toxicity to aquatic algae and cyanobacteria (6.1.5) | If available | |
| Toxicity to aquatic plants other than algae (6.1.6) | If available | |
| Toxicity to microorganisms (6.1.7) | If available | |
| Endocrine disruptor testing in aquatic vertebrates – in vivo (6.1.8) | If available | |
| Toxicity to other aquatic vertebrates (6.1.9) | If available | |
| Sediment toxicity (6.2) | If available | |
| Toxicity to soil macroorganisms except arthropods (6.3.1) | If available | |
| Toxicity to terrestrial arthropods (6.3.2) | If available | |
| Toxicity to terrestrial plants (6.3.3) | If available | |
| Toxicity to soil microorganisms (6.3.4) | If available | |
| Additional ecotoxicological information (6.6) | If available | |
| 7. Toxicological information | Basic toxicokinetics (7.1.1) | If available |
| Dermal absorption (7.1.2) | If available | |
| Acute toxicity: oral (7.2.1) | If available | |
| Acute toxicity: inhalation (7.2.2) | If available | |
| Acute toxicity: dermal (7.2.3) | If available | |
| Acute toxicity: other routes (7.2.4) | If available | |
| Skin irritation / corrosion (7.3.1) | If available | |
| Eye irritation (7.3.2) | If available | |
| Skin sensitisation (7.4.1) | If available | |
| Respiratory sensitisation (7.4.2) | If available | |
| Repeated dose toxicity: oral (7.5.1) | If available | |
| Repeated dose toxicity: inhalation (7.5.2) | If available | |
| Repeated dose toxicity: dermal (7.5.3) | If available | |
| Repeated dose toxicity: other routes (7.5.4) | If available | |
| Genetic toxicity in vitro (7.6.1) | If available | |
| Genetic toxicity in vivo (7.6.2) | If available | |
| Carcinogenicity (7.7) | If available | |
| Toxicity to reproduction (7.8.1) | If available | |
| Developmental toxicity / teratogenicity (7.8.2) | If available | |
| Toxicity to reproduction: other studies (7.8.3) | If available | |
| Neurotoxicity (7.9.1) | If available | |
| Immunotoxicity (7.9.2) | If available | |
| Specific investigations: other studies (7.9.4) | If available | |
| Health surveillance data (7.10.1) | If available | |
| Epidemiological data (7.10.2) | If available | |
| Direct observations: clinical cases, poisoning incidents and other (7.10.3) | If available | |
| Sensitisation data (humans) (7.10.4) | If available | |
| Exposure related observations in humans: other data (7.10.5) | If available | |
| Additional toxicological information (7.12) | If available | |
| 9. Residues in food and feeding stuff | If available | |
| 11. Guidance on safe use | Required | |
| 13. Assessment report (attach SDS) | Required | |
Reminder about the information you need to support the application type you've chosen
For all application types (except for health and environment focus), you must have sufficient supporting information to demonstrate the absence of hazard characteristics based on the acceptable test guidelines.
Additional application type - comparable hazard assessment
A comparable hazard assessment is a type of assessment certificate application. In AICIS Business Services, we'll ask you if you are using an acceptable comparable hazard assessment.
Choose this if your introduction has had a hazard assessment previously conducted by an acceptable overseas or Australian assessment body.
Assessment bodies we recognise
For assessment bodies, one of the following overseas or Australian assessment bodies must have already assessed your introduction.
- National Industrial Chemicals Notification and Assessment Scheme (NICNAS)
- Australian Industrial Chemicals Introduction Scheme (AICIS)
- Environment and Climate Change Canada (ECCC) / Health Canada (HC) – (certain Schedules)
- United States Environmental Protection Agency (US EPA)
- European Commission (EC) Scientific Committee on Consumer Safety (SCCS) or its equivalent former committees — the Scientific Committee on Consumer Products (SCCP) and the Scientific Committee on Cosmetic Products and Non-Food Products (SCCNFP)
- Therapeutic Goods Administration (TGA)
- Australian Pesticides and Veterinary Medicines Authority (APVMA)
- Food Standards Australia New Zealand (FSANZ)
- International parallel process assessments where Australia was involved as a secondary jurisdiction and Environment and Climate Change Canada (ECCC) / Health Canada (HC) or the United States Environmental Protection Agency (US EPA) performed the risk assessment
Contact us if you’d like to know more about eligible assessments and how to get permission to use them.
How to apply for a comparable hazard assessment
Before you start your application, you will need to contact us for further guidance.
Information for publication purposes
We may use information on the purity, volume and/or concentration in a defined scope of assessment for an assessment certificate.
You need to agree with all participants the information that, for publication purposes, will be entered into AICIS Business Services about:
- Purity – it must be a number between 0 and 100 with no more than 2 decimal digits
- Volume – tonnes of the chemical to be introduced each year
- Concentration – introduction and end use concentration.